Science CAR-T Therapy Shows Promise for H3K27M-Mutant Diffuse Midline Gliomas Research into chimeric antigen receptor-modified T cell (CAR-T) therapy targeting GD2 is advancing as a potential treatment for patients with diffuse midline gliomas characterized... Editorial7 hours ago